SKI Market

Indian Indices

Sensex

83,570.35 187.64
( 0.23%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,996.71 -113.79
(-0.21%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Syncom Formulations (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524470

INE312C01025

4.0048596

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYNCOMF

19.36

1219.18

EPS(TTM)

Face Value()

Div & Yield %

0.67

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	462.85	258.36	224.64	219.66	244.81	205.51
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	462.85	258.36	224.64	219.66	244.81	205.51
Other Income	17.20	13.10	14.62	12.02	7.17	5.22
Stock Adjustments	10.62	2.18	-0.05	-3.32	4.05	3.70
Total Income	490.67	273.64	239.21	228.36	256.03	214.43
EXPENDITURE :
Raw Materials	317.51	157.74	142.07	137.23	165.51	155.32
Power & Fuel Cost	5.62	6.13	5.31	4.38	3.84	3.93
Employee Cost	50.56	33.57	24.44	20.73	18.24	15.80
Other Manufacturing Expenses	2.88	2.39	3.19	2.26	2.09	2.02
Selling & Administrative Expenses	39.22	29.62	27.29	29.71	19.79	13.76
Miscellaneous Expenses	4.00	3.03	2.41	2.00	1.34	1.65
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	419.79	232.47	204.71	196.32	210.81	192.47
Operating Profit	70.88	41.18	34.51	32.05	45.22	21.96
Interest	1.03	4.70	3.40	1.93	0.48	0.61
Gross Profit	69.85	36.48	31.11	30.12	44.74	21.35
Depreciation	5.19	4.72	4.54	3.95	4.03	4.06
Profit Before Tax	64.66	31.76	26.57	26.17	40.71	17.29
Tax	14.45	7.58	6.65	6.25	11.30	4.43
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.33	0.55	-0.15	0.14	0.23	-1.40
Reported Net Profit	48.87	23.62	20.07	19.79	29.17	14.25
Extraordinary Items	0.32	0.55	0.14	0.03	0.10	-0.04
Adjusted Net Profit	48.55	23.07	19.93	19.76	29.07	14.29
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	102.99	79.36	62.11	42.32	13.15	11.40
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	2.82	0.00	0.00	12.50
P & L Balance carried down	151.86	102.99	79.36	62.11	42.32	13.15
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	3.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.03	0.00	0.00
Earnings Per Share-Unit Curr	0.52	0.25	0.21	0.23	0.37	0.18
Earnings Per Share(Adj)-Unit Curr	0.52	0.25	0.21	0.23	0.37	0.18
Book Value-Unit Curr	3.62	3.05	2.72	2.52	2.25	1.87
Book Value(Adj)-Unit Curr	3.62	3.05	2.72	2.52	2.25	1.87

83,570.35 187.64 ( 0.23%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,996.71 -113.79 (-0.21%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)